OSLO, Norway--(BUSINESS WIRE)--Regulatory News: On 18 April 2012 mandatory notification of trade among primary insider Praveen Sharma of DiaGenic ASA (OSE:DIAG) took place. Capveen AS, which is controlled by Sharma, has sold 266,213 shares to Praveen Sharma at NOK 2.45 per share. After this transaction, Capveen AS holds no shares in DiaGenic and Praveen Sharma holds 515,290 shares in DiaGenic in addition to 16.000 share options. Sharma has increased his exposure in DiaGenic ASA by this transaction.
